Literature DB >> 6380014

Zymodeme and species specificities of monoclonal antibodies raised against Trypanosoma cruzi.

J E Flint, M Schechter, M D Chapman, M A Miles.   

Abstract

A series of hybrid cell lines was generated by the fusion of Sp2/0 myeloma cells with spleen cells from BALB/c mice that had been immunized or infected with Trypanosoma cruzi zymodemes (Z1, Z2, Z3 ). Four immunoglobulin isotypes, IgM, IgG1, IgG2a and IgG3 were represented amongst the monoclonal antibodies secreted by 22 hybridoma clones. On indirect immunofluorescence (IFAT) antibodies bound to flagellum, cytoplasm, cell membrane or stained the whole organism. Two antibodies were epimastigote-specific. Enzyme-linked immunosorbent assays (ELISA) and a dot immunobinding test were used to evaluate the zymodeme and species specificities of 13 antibodies: four reacted with all T. cruzi zymodemes tested, two reacted strongly with all except Z1, two predominantly with Z1, two predominantly with Z2, and three predominantly with Z3 . Two IgM antibodies cross reacted with Trypanosoma rangeli, T. brucei, Leishmania mexicana, L. braziliensis and L. donovani. Five antibodies were used in a preliminary immunobinding test, performed blindly, to compare monoclonal reactivities and zymodeme groups. The results suggested a correlation between the two methods of characterization. Anti-T. cruzi monoclonal antibodies are considered to have important applications to epidemiological studies and the improved diagnosis and prognosis of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380014     DOI: 10.1016/0035-9203(84)90276-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Trypanosoma cruzi glycoprotein 72: immunological analysis and cellular localization.

Authors:  G Harth; A A Mills; T Souto-Padrón; W de Souza
Journal:  Mol Cell Biochem       Date:  1992-01-15       Impact factor: 3.396

2.  Species-specific monoclonal antibodies for a membrane antigen(s) in all developmental forms of Trypanosoma cruzi.

Authors:  H Tachibana; K Nagakura; Y Kaneda
Journal:  Z Parasitenkd       Date:  1986

3.  Prevalence of antibodies to 72-kilodalton glycoprotein (GP72) in patients with Chagas' disease and further evidence of zymodeme-associated expression of GP72 carbohydrate epitopes.

Authors:  M Schechter; A F Stevens; A O Luquetti; D Snary; A K Allen; M A Miles
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi.

Authors:  R A Wrightsman; W Leon; J E Manning
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure.

Authors:  M Tibayrenc; P Ward; A Moya; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  Purification of metacyclic trypomastigotes of Trypanosoma cruzi and Trypanosoma dionisii from culture using an epimastigote-specific monoclonal antibody.

Authors:  K Petry; J Schottelius; T Baltz
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

7.  Characterization of a glycosyl-phosphatidylinositol-anchored membrane protein from Trypanosoma cruzi.

Authors:  C Hernández-Munaín; M A Fernández; A Alcina; M Fresno
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.